2120 Stock Overview
Operates a network of healthcare facilities in the People’s Republic of China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 4/6 |
| Dividends | 3/6 |
Wenzhou Kangning Hospital Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$12.80 |
| 52 Week High | HK$15.90 |
| 52 Week Low | HK$9.99 |
| Beta | 0.15 |
| 11 Month Change | 4.40% |
| 3 Month Change | -6.57% |
| 1 Year Change | -1.54% |
| 33 Year Change | -53.96% |
| 5 Year Change | -39.91% |
| Change since IPO | -73.93% |
Recent News & Updates
Recent updates
Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Share Price Matching Investor Opinion
Sep 26
We Think The Compensation For Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) CEO Looks About Right
May 23Estimating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Feb 28Investors Continue Waiting On Sidelines For Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jan 19Wenzhou Kangning Hospital (HKG:2120) Has A Somewhat Strained Balance Sheet
Nov 23Wenzhou Kangning Hospital (HKG:2120) Could Be Struggling To Allocate Capital
Jun 16Returns Are Gaining Momentum At Wenzhou Kangning Hospital (HKG:2120)
Mar 23Is Wenzhou Kangning Hospital (HKG:2120) Using Too Much Debt?
Dec 06Returns On Capital Are Showing Encouraging Signs At Wenzhou Kangning Hospital (HKG:2120)
Aug 11Calculating The Fair Value Of Wenzhou Kangning Hospital Co., Ltd. (HKG:2120)
Jul 09Wenzhou Kangning Hospital (HKG:2120) Is Experiencing Growth In Returns On Capital
May 12Wenzhou Kangning Hospital (HKG:2120) Has A Pretty Healthy Balance Sheet
Apr 10Wenzhou Kangning Hospital Co., Ltd.'s (HKG:2120) Stock Has Shown Weakness Lately But Financial Prospects Look Decent: Is The Market Wrong?
Feb 25Will Wenzhou Kangning Hospital (HKG:2120) Multiply In Value Going Forward?
Jan 17
Should You Use Wenzhou Kangning Hospital's (HKG:2120) Statutory Earnings To Analyse It?
Dec 23If You Had Bought Wenzhou Kangning Hospital's (HKG:2120) Shares Five Years Ago You Would Be Down 42%
Dec 10Can Mixed Fundamentals Have A Negative Impact on Wenzhou Kangning Hospital Co., Ltd. (HKG:2120) Current Share Price Momentum?
Nov 27Shareholder Returns
| 2120 | HK Healthcare | HK Market | |
|---|---|---|---|
| 7D | 0.2% | -1.5% | -0.6% |
| 1Y | -1.5% | -27.6% | 9.6% |
Return vs Industry: 2120 exceeded the Hong Kong Healthcare industry which returned -27.6% over the past year.
Return vs Market: 2120 underperformed the Hong Kong Market which returned 9.6% over the past year.
Price Volatility
| 2120 volatility | |
|---|---|
| 2120 Average Weekly Movement | 5.7% |
| Healthcare Industry Average Movement | 7.9% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.0% |
| 10% least volatile stocks in HK Market | 4.2% |
Stable Share Price: 2120 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: 2120's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 4,742 | Lianyue Wang | www.knhosp.cn |
Wenzhou Kangning Hospital Co., Ltd. operates a network of healthcare facilities in the People’s Republic of China. It primarily focuses on providing psychiatric specialty care and elderly rehabilitation services. The company also provides property leasing and sale services; and information technology services, as well as hospital management, judicial expertise, internet hospital platform, nursing care, and medical services.
Wenzhou Kangning Hospital Co., Ltd. Fundamentals Summary
| 2120 fundamental statistics | |
|---|---|
| Market cap | HK$916.13m |
| Earnings (TTM) | HK$99.83m |
| Revenue (TTM) | HK$1.77b |
9.2x
P/E Ratio0.5x
P/S RatioIs 2120 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 2120 income statement (TTM) | |
|---|---|
| Revenue | CN¥1.65b |
| Cost of Revenue | CN¥1.23b |
| Gross Profit | CN¥421.64m |
| Other Expenses | CN¥328.72m |
| Earnings | CN¥92.92m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.30 |
| Gross Margin | 25.60% |
| Net Profit Margin | 5.64% |
| Debt/Equity Ratio | 64.7% |
How did 2120 perform over the long term?
See historical performance and comparison